Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia Grant US-11918558-B2 United States of America 05 Mar 2024
Tinostamustine for use in treating ovarian cancer Grant US-11896583-B2 United States of America 13 Feb 2024
Pharmaceutical combinations for treating cancer Grant US-11559516-B2 United States of America 24 Jan 2023
Combination comprising a glucocorticoid and EDO-S101 Grant US-11541038-B2 United States of America 03 Jan 2023
Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia Grant US-11318117-B2 United States of America 03 May 2022
Combination comprising a glucocorticoid and EDO-S101 Grant US-10744120-B2 United States of America 18 Aug 2020
Oral dosage forms of bendamustine and therapeutic use thereof Application US-10485787-B2 United States of America 26 Nov 2019
Pharmaceutical combinations for treating cancer Grant US-10406138-B2 United States of America 10 Sep 2019
Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and… Grant US-9993482-B2 United States of America 12 Jun 2018
COMBINED USE OF BENDAMUSTINE, DOXORUBICIN AND BORTEZOMIB FOR THE TREATMENT OF MULTIPLE… Application EP-2350665-A4 European Patent Office 06 Jun 2012
COMBINED USE OF BENDAMUSTINE, DOXORUBICIN AND BORTEZOMIB FOR THE TREATMENT OF MULTIPLE… Application EP-2350665-A1 European Patent Office 03 Aug 2011